https://pharmoniq.com/news/clear-eyes-maximum-itchy-eye-relief-recalled-contamination-risk PharmoniQ en 2026-08-22T14:10:49.226Z Clear Eyes Maximum Itchy Eye Relief Recalled Over Contamination Risk FDA recall, eye drops, contamination, OTC safety, ophthalmic products https://pharmoniq.com/news/china-nmpa-40-novel-drug-approvals-2025-innovation-surge PharmoniQ en 2026-08-22T08:47:02.809Z China's NMPA Records 40 First-Time Approvals in 2025 as Innovation Accelerates NMPA, China pharmaceutical, drug approvals, regulatory reform, global pharma https://pharmoniq.com/news/landmark-cancer-vaccine-fda-review-oncology-milestone PharmoniQ en 2026-08-21T14:10:49.719Z Landmark Cancer Vaccine Enters FDA Review, Signals Oncology Shift cancer vaccine, FDA review, oncology, immunotherapy, clinical trials